IFF · International Flavors & Fragrances Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · IFF

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$10.89B	$11.48B	$11.48B	$12.44B	$11.66B	$5.08B
Cost of Revenue	$6.95B	$7.36B	$7.80B	$8.29B	$7.92B	$3.00B
Gross Profit	$3.94B	$4.12B	$3.68B	$4.15B	$3.73B	$2.09B
R&D	$694.00M	$671.00M	$636.00M	$603.00M	$629.00M	$356.86M
SG&A	$1.83B	$2.00B	$1.79B	$1.77B	$1.75B	$948.83M
Total Operating Expenses	-	-	-	-	-	-
D&A	$962.00M	$1.01B	$1.14B	$1.18B	$1.16B	$325.36M
Operating Income	($382.00M)	$766.00M	($2.11B)	($1.33B)	$585.00M	$566.48M
Interest Expense	$229.00M	$305.00M	$380.00M	$336.00M	$289.00M	$131.80M
Income Tax	($53.00M)	$31.00M	$45.00M	$239.00M	$75.00M	$74.00M
Net Income	($361.00M)	$243.00M	($2.57B)	($1.87B)	$270.00M	$363.23M
EPS - Basic	($1.41)	$0.95	($10.05)	($7.32)	$1.11	$3.25
EPS - Diluted	($1.41)	$0.95	($10.05)	($7.32)	$1.10	$3.21

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$590.00M	$469.00M	$703.00M	$483.00M	$711.00M	$649.54M
Accounts Receivable	$1.73B	$1.62B	$1.73B	$1.82B	$1.91B	$929.30M
Inventory	$2.25B	$2.13B	$2.48B	$3.15B	$2.52B	$1.13B
Accounts Payable	$1.29B	$1.28B	$1.38B	$1.42B	$1.53B	$555.69M
Current Assets	$5.59B	$7.99B	$6.29B	$7.43B	$6.99B	$3.06B
Total Assets	$25.54B	$28.67B	$30.98B	$35.41B	$39.66B	$13.56B
Current Liabilities	$3.93B	$4.33B	$3.76B	$3.73B	$3.63B	$1.90B
Long-term Debt	$4.74B	$7.56B	$9.19B	$10.37B	$10.77B	$3.78B
Total Liabilities	-	-	-	-	-	-
Stockholders' Equity	$14.15B	$13.88B	$14.61B	$17.68B	$21.08B	$6.31B
Retained Earnings	($3.42B)	($2.60B)	($2.44B)	$955.00M	$3.64B	$4.16B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$850.00M	$1.07B	$1.44B	$397.00M	$1.44B	$714.10M
Investing Cash Flow	$2.27B	$326.00M	$574.00M	$745.00M	($18.00M)	($187.46M)
Financing Cash Flow	($3.09B)	($1.61B)	($1.85B)	($1.23B)	($1.30B)	($511.57M)
CapEx	$594.00M	$463.00M	$503.00M	$504.00M	$393.00M	$191.79M
Free Cash Flow	$256.00M	$607.00M	$936.00M	($107.00M)	$1.04B	$522.30M

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	36.2%	35.9%	32.1%	33.4%	32.0%	41.0%
Operating margin	-3.5%	6.7%	-18.4%	-10.7%	5.0%	11.1%
EBITDA margin	5.3%	15.5%	-8.4%	-1.2%	14.9%	17.5%
Net margin	-3.3%	2.1%	-22.4%	-15.0%	2.3%	7.1%
Free cash flow margin	2.4%	5.3%	8.2%	-0.9%	9.0%	10.3%
FCF / Net income	-0.71	2.50	-0.36	0.06	3.87	1.44
R&D / Revenue	6.4%	5.8%	5.5%	4.8%	5.4%	7.0%
SG&A / Revenue	16.8%	17.4%	15.6%	14.2%	15.0%	18.7%
Effective tax rate	-	11.3%	-	-	21.7%	16.9%
Return on assets	-1.4%	0.8%	-8.3%	-5.3%	0.7%	2.7%
Return on equity	-2.6%	1.8%	-17.6%	-10.6%	1.3%	5.8%
Return on invested capital	-1.6%	3.2%	-7.0%	-3.7%	1.4%	4.7%
Liquidity
Current ratio	1.42	1.84	1.67	1.99	1.92	1.61
Quick ratio	0.85	1.35	1.02	1.15	1.23	1.01
Cash ratio	0.15	0.11	0.19	0.13	0.20	0.34
Leverage
Debt / Equity	0.33	0.55	0.63	0.59	0.51	0.60
Debt / Assets	0.19	0.26	0.30	0.29	0.27	0.28
Debt / EBITDA	8.17	4.25	-	-	6.18	4.24
Interest coverage	-1.7x	2.5x	-5.6x	-3.9x	2.0x	4.3x
Equity multiplier	1.80	2.07	2.12	2.00	1.88	2.15
Liabilities / Assets	-	-	-	-	-	-
Efficiency
Asset turnover	0.43	0.40	0.37	0.35	0.29	0.38
Inventory turnover	3.10	3.45	3.15	2.63	3.15	2.65
Days sales outstanding	58d	52d	55d	53d	60d	67d
Days inventory outstanding	118d	106d	116d	139d	116d	138d
Days payable outstanding	68d	64d	64d	62d	71d	68d
Cash conversion cycle	108d	94d	106d	130d	105d	137d
Valuation
P / E	-	89.0x	-	-	137.0x	33.9x
P / B	1.2x	1.6x	1.4x	1.5x	1.7x	2.0x
P / S	1.6x	1.9x	1.8x	2.1x	3.1x	2.4x
EV / EBITDA	36.9x	16.1x	-	-	26.8x	17.4x
Growth
Revenue growth (YoY)	-5.2%	0.0%	-7.7%	6.7%	129.3%	-1.1%
Revenue CAGR (3y)	-4.3%	-0.5%	31.2%	34.3%	55.2%	-
Revenue CAGR (5y)	16.5%	17.4%	29.8%	-	-	-
Gross profit growth (YoY)	-4.5%	12.0%	-11.3%	11.1%	79.1%	-1.3%
Operating income growth (YoY)	-	-	-59.1%	-	3.3%	-14.8%
Net income growth (YoY)	-	-	-37.2%	-	-25.7%	-20.3%
EPS growth (YoY)	-	-	-37.3%	-	-65.7%	-19.8%
EPS CAGR (3y)	-	-4.8%	-	-	-33.8%	-4.8%
EPS CAGR (5y)	-	-25.0%	-	-	-26.3%	-9.1%
FCF growth (YoY)	-57.8%	-35.1%	-	-	99.9%	12.8%
FCF CAGR (5y)	-13.3%	5.6%	28.5%	-	20.6%	9.4%
Book value growth (YoY)	2.0%	-5.0%	-17.4%	-16.1%	234.0%	1.5%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$10.89B total

Food Ingredients$3.28B · 30.1%

Taste$2.48B · 22.8%

Scent$2.48B · 22.8%

Health And Biosciences$2.28B · 21.0%

Pharma Solutions$369.00M · 3.4%

Geographic

$10.89B total

EMEA$3.73B · 34.2%

North America$3.19B · 29.3%

Asia$2.55B · 23.4%

Latin America$1.42B · 13.1%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

6/9

Neutral

✗Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✗Current ratio improved
✓No share dilution
✓Gross margin improved
✓Asset turnover improved

Peer comparison

Same SIC group: Industrial Organic Chemicals

Company	Revenue (last FY)	Net margin	ROE
LYB	$30.15B	-2.4%	-7.3%
SXT	$1.61B	8.3%	11.3%
WLK	$11.17B	-13.5%	-17.2%
GEVO	$160.58M	-21.1%	-7.3%
GPRE	$2.09B	-5.8%	-15.8%

Comparing INTERNATIONAL FLAVORS & FRAGRANCES INC against the 5 most active filers in the same SIC group.

Dividends

$1.60/share trailing 12 months · 0.0% YoY

Ex-date	Per share
Mar 20, 2026	$0.4000
Dec 19, 2025	$0.4000
Sep 29, 2025	$0.4000
Jun 20, 2025	$0.4000
Mar 21, 2025	$0.4000
Dec 20, 2024	$0.4000
Sep 20, 2024	$0.4000
Jun 21, 2024	$0.4000
Mar 21, 2024	$0.4000
Dec 27, 2023	$0.8100
Sep 21, 2023	$0.8100
Jun 22, 2023	$0.8100
Mar 23, 2023	$0.8100
Dec 27, 2022	$0.8100
Sep 22, 2022	$0.8100
Jun 23, 2022	$0.7900
Mar 24, 2022	$0.7900
Dec 27, 2021	$0.7900
Sep 23, 2021	$0.7900
Jun 24, 2021	$0.7700
Mar 25, 2021	$0.7700
Dec 24, 2020	$0.7700
Sep 23, 2020	$0.7700
Jun 24, 2020	$0.7500